223 related articles for article (PubMed ID: 22271298)
21. The adverse event profile of lacosamide: a systematic review and meta-analysis of randomized controlled trials.
Zaccara G; Perucca P; Loiacono G; Giovannelli F; Verrotti A
Epilepsia; 2013 Jan; 54(1):66-74. PubMed ID: 22779776
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of pregabalin in patients with neuropathic cancer pain undergoing morphine therapy.
Dou Z; Jiang Z; Zhong J
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e57-e64. PubMed ID: 25530068
[TBL] [Abstract][Full Text] [Related]
23. Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials.
Häuser W; Bernardy K; Uçeyler N; Sommer C
Pain; 2009 Sep; 145(1-2):69-81. PubMed ID: 19539427
[TBL] [Abstract][Full Text] [Related]
24. A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings.
Navarro A; Saldaña MT; Pérez C; Torrades S; Rejas J
BMC Neurol; 2011 Jan; 11():7. PubMed ID: 21251268
[TBL] [Abstract][Full Text] [Related]
25. A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions.
Roth T; Arnold LM; Garcia-Borreguero D; Resnick M; Clair AG
Sleep Med Rev; 2014 Jun; 18(3):261-71. PubMed ID: 24119681
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.
Beydoun A; Uthman BM; Kugler AR; Greiner MJ; Knapp LE; Garofalo EA;
Neurology; 2005 Feb; 64(3):475-80. PubMed ID: 15699378
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
28. [Pregabalin--a neuromodulator for the treatment of neuropathic pain, generalized anxiety disorders and fibromyalgia syndrome].
Nymdelger S; Nieber K
Med Monatsschr Pharm; 2007 Nov; 30(11):396-400. PubMed ID: 18062330
[TBL] [Abstract][Full Text] [Related]
29. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
Mease PJ; Russell IJ; Arnold LM; Florian H; Young JP; Martin SA; Sharma U
J Rheumatol; 2008 Mar; 35(3):502-14. PubMed ID: 18278830
[TBL] [Abstract][Full Text] [Related]
30. Impact of gastrointestinal symptoms on response to pregabalin in generalized anxiety disorder: results of a six-study combined analysis.
Stein DJ; Bruce Lydiard R; Herman BK; Mandel FS
Int Clin Psychopharmacol; 2009 May; 24(3):126-32. PubMed ID: 19352198
[TBL] [Abstract][Full Text] [Related]
31. Pregabalin: a new antiepileptic drug for refractory epilepsy.
Hamandi K; Sander JW
Seizure; 2006 Mar; 15(2):73-8. PubMed ID: 16413993
[TBL] [Abstract][Full Text] [Related]
32. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
Arnold LM; Russell IJ; Diri EW; Duan WR; Young JP; Sharma U; Martin SA; Barrett JA; Haig G
J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684
[TBL] [Abstract][Full Text] [Related]
33. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.
Arnold LM; Emir B; Murphy TK; Zeiher BG; Pauer L; Scott G; Petersel D
Clin Ther; 2012 May; 34(5):1092-102. PubMed ID: 22503162
[TBL] [Abstract][Full Text] [Related]
34. Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: better pain relief, sleep and physical health.
Mańas A; Ciria JP; Fernández MC; Gonzálvez ML; Morillo V; Pérez M; Masramon X; López-Gómez V;
Clin Transl Oncol; 2011 Sep; 13(9):656-63. PubMed ID: 21865137
[TBL] [Abstract][Full Text] [Related]
35. Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder.
Lydiard RB; Rickels K; Herman B; Feltner DE
Int J Neuropsychopharmacol; 2010 Mar; 13(2):229-41. PubMed ID: 19737439
[TBL] [Abstract][Full Text] [Related]
36. [Use of pregabalin and sertraline in complex treatment of patients with partial epilepsy comorbid with depressive and anxiety disorders].
Bondarenko II; Kissin MIa
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):29-36. PubMed ID: 22951778
[TBL] [Abstract][Full Text] [Related]
37. Pregabalin: new drug. Very similar to gabapentin.
Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
[TBL] [Abstract][Full Text] [Related]
38. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy.
Brodie MJ; Wilson EA; Wesche DL; Alvey CW; Randinitis EJ; Posvar EL; Hounslow NJ; Bron NJ; Gibson GL; Bockbrader HN
Epilepsia; 2005 Sep; 46(9):1407-13. PubMed ID: 16146435
[TBL] [Abstract][Full Text] [Related]
39. Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis.
Tzellos TG; Toulis KA; Goulis DG; Papazisis G; Zampeli VA; Vakfari A; Kouvelas D
J Clin Pharm Ther; 2010 Dec; 35(6):639-56. PubMed ID: 21054455
[TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: an overview with network meta-analysis.
Alberti FF; Becker MW; Blatt CR; Ziegelmann PK; da Silva Dal Pizzol T; Pilger D
Clin Rheumatol; 2022 Jul; 41(7):1965-1978. PubMed ID: 35347488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
